2010 annual financial data
Halozyme Therapeutics 2010 Financial results
Direct answer
Revenue was 13,624,115 USD.
Operating income was -54,257,632 USD and net income was -53,241,650 USD.
Operating cash flow was -45,385,506 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,624,115 USD
- Operating income
- -54,257,632 USD
- Net income
- -53,241,650 USD
- Operating cash flow
- -45,385,506 USD
Explore related company data
View all 2010 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Halozyme Therapeutics financial years